Lenvatinib Mesylate Intermediate CAS 205448-65-3 Ịdị ọcha> Ụlọ ọrụ 98.0% (HPLC)

Nkọwa dị mkpirikpi:

Aha Kemịkal: Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate

CAS: 205448-65-3

Dị ọcha:> 98.0% (HPLC)

Ọdịdị: Gbanyụọ-Ọcha ruo ntụ ntụ edo edo

Ọkara nke Lenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Njirimara kemịkalụ:

Aha Chemical Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate
Ụdị okwu 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Ọkara Lenvatinib 3
Nọmba CAS 205448-65-3
Nọmba CAT RF-PI1973
Ọnọdụ Ahịa N'ahịa, Ikike Mmepụta 50 MT/Afọ
Usoro ihe omimi C12H11NO4
Ibu molekụla 233.22
Ebe esi nri 421.0± 45.0 ℃
Njupụta 1.267±0.060 g/cm3
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Gbanyụọ-Ọcha ruo ntụ ntụ edo edo
Ụzọ ịdị ọcha / nyocha > 98.0% (HPLC)
Ọnwụ na ihicha <1.00%
Ihe fọdụrụ na mgbanye <0.50%
Mgbakọta adịghị ọcha <2.00%
H-NMR Dabara na Ọdịdị
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ndị na-ahụ maka ọgwụ

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

1

Ajụjụ:

Ngwa:

Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) bụ etiti nke Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib, nke a na-ere n'okpuru aha aha Lenvima n'etiti ndị ọzọ, bụ ọgwụ na-egbochi ọrịa cancer maka ọgwụgwọ ụfọdụ ụdị ọrịa cancer thyroid yana maka ọrịa cancer ndị ọzọ.Emepụtara ya bụ Eisai Co. ma na-eme dị ka onye na-egbochi ọtụtụ kinase megide VEGFR1, VEGFR2 na VEGFR3 kinases.A kwadoro Lenvatinib (ebe ọ bụ na 2015) maka ọgwụgwọ ọrịa cancer thyroid dị iche iche nke na-emeghachi ugboro ugboro ma ọ bụ metastatic, na-aga n'ihu, na-anabataghị ọgwụgwọ na radioactive iodine (radioiodine).Na May 2016, US Food and Drug Administration (FDA) kwadoro ya (na njikọ ya na everolimus) maka ọgwụgwọ nke carcinoma renal cell carcinoma na-esote otu tupu ọgwụgwọ angiogenic.A kwadokwara ọgwụ ahụ na US na na European Union maka hepatocellular carcinoma nke enweghị ike iwepụ n'ịwa ahụ na ndị ọrịa na-enwetabeghị ọgwụgwọ ọrịa kansa site n'ọnụ ma ọ bụ ntụtụ.

Dee ozi gị ebe a ziga anyị ya